Compass Therapeutics, Inc. (CMPX)

Compass Therapeutics, Inc. (CMPX) is a healthcare company (biotechnology) based in the United States. The share price is $0.61, down 8.28% on the day, which values the company at $109.26M. Price as of 18 Nov 2026, 12:25 UTC, from Yahoo Finance.

Key facts

Share price
$0.61−8.28% today
Market value
$109.26M
200-week average
$2.6077% below
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

Compass Therapeutics, Inc. in more detail

CMPX trades at -1.0× next year's expected earnings. It sits 77% below its 200-week average of $2.60.

In its favour: More cash than debt. Worth checking: Share count keeps rising; Debt is growing faster than cash flow.

Compass Therapeutics, Inc. (CMPX): questions and answers

What is Compass Therapeutics, Inc.'s market cap?

Compass Therapeutics, Inc. is valued at $109.26M at a share price of $0.61.

Is CMPX above its 200-week moving average?

No. CMPX is 76.7% below its 200-week average of $2.60. Long-term investors watch that line because strong companies rarely trade below it for long.

Does CMPX pay a dividend?

Compass Therapeutics, Inc. does not currently pay a regular dividend.

Cite this page

Funkfolio, “Compass Therapeutics, Inc. (CMPX) stock: price, valuation and fundamentals”, data as of 18 November 2026. https://funkfolio.com/stock/CMPX

Underlying data: Yahoo Finance; company filings with the SEC.